Lee, Hyojin
Jeong, Moonsup
Oh, Jooyeon
Cho, Youngran
Shen, Xuefei
Stone, John
Yan, Jian
Rothkopf, Zachary
Khan, Amir S.
Cho, Byung Mun
Park, Young K.
Weiner, David B.
Son, Woo-Chan
Maslow, Joel N.
Article History
Received: 26 August 2016
Accepted: 25 January 2017
First Online: 7 March 2017
Competing interests
: H.L., M.J., J.O., Y.C., B.C., Y.K.P., and J.N.M. own stock or stock options in and are paid employees of GeneOne Life Science, Inc., co-developer VGX-6150. X.S., J.S., J.Y., and A.S.K., own stock or stock options in and are paid employees of Inovio Pharmaceuticals, Inc., co-developer of VGX-6150. J.N.M., Y.K.P., and D.B.W. own stock or stock options in Inovio Pharmaceuticals, Inc. D.B.W. serves on the Board of Directors of Inovio Pharmaceuticals, Inc. The other authors have no conflicts of interest to report.